Top Story COVID-19 pandemic: Plea in Delhi HC wants control on...

COVID-19 pandemic: Plea in Delhi HC wants control on treatment expenses imposed

-

New Delhi, May 20 (ILNS): A petition was filed in the Delhi High Court, demanding control on the cost of treatment incurred by COVID-19 patients in private hospitals by way of directions to private hospitals to publish on their website, the regulated rates as well as show in prominent places inside the hospitals.

The petition, filed by Advocate Vivek Aggarwal, will come up for hearing on May 31. It also demanded punitive action for non-compliance of guidelines by the Central and Delhi government.

The plea sought the following directions to the Central Government and the Delhi Government:

• Direction to establish a committee headed by a retired Judge of the High Court of Delhi to keep a check on admissions of COVID-19 patients and implementation of admission policy. Directions to the said committee to conduct regular audits to ensure compliance of the admissions policy and penalising the defaulting private hospitals.

• Directions to create and implement a policy to establish a supply chain of the drug Remdesivir and drug Tocilizumab directly to hospitals only on the price cap/regulated price of the drug Remdesivir and drug Tocilizumab, respectively as and when fixed by the Union of India and further restrain the Governments from supplying the drug Remdesivir and drug Tocilizumab to private physicians, pharmacists, chemists, entities and other bodies who are black marketing the said medicines.

• Direction to establish a committee headed by a retired judge of the High Court of Delhi to keep a check on admissions of Covid-19 patients and implementation of admission policy and further direct the said committee to conduct regular audits to ensure compliance of the admissions policy and penalize defaulting private hospitals.

• Direction to create and implement a policy to establish a supply chain of the drug Remdesivir and drug Tocilizumab directly to hospitals only on the price cap/regulated price of the drug Remdesivir and drug Tocilizumab respectively as and when fixed by the Union of India (respondent no.1) and further restrain the respondents from supplying the drug Remdesivir and drug Tocilizumab to private physicians, pharmacists, chemists, entities and other bodies who are black marketing the said medicines.

• Directions to establish a committee headed by a retired judge of the High Court of Delhi to keep a check on the production, supply and usage of drug Remdesivir and drug Tocilizumab in hospitals and create a database thereof and conduct regular audits to ensure requisite supply is provided to the hospitals in need.

• Direction to appoint nodal officers in hospitals to look into the sale of drug Remdesivir and Tocilizumab at the regulated price decided by the Government in consultation with the respective hospital administration and establish an online portal which is updated hourly to track the availability and usage of the drug Remdesivir and drug Tocilizumab in respective hospitals and in every district.

• Direction to establish 24*7 national, state and local helplines to address the enquiries regarding the availability of the drug Remdesivir and drug Tocilizumab and further set up centralized control rooms at district level to provide information on the availability of the drug Remdesivir, drug Tocilizumab, and availability of beds.

• Direction to regulate the price of oxygen cylinders and concentrators and further regulate the price for refilling the oxygen cylinders and concentrators.

• Direction for thorough investigation by a duly formed Special Investigation Team (SIT) to look into the sale of the drug Remdesivir and drug Tocilizumab, sale of oxygen cylinders, concentrators, allotment of beds in hospitals for money. ILNS\ABV\SJ\RJ

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

SC pulls up UPSC, Jharkhand PSC for violating DGP appointment rules

The Supreme Court has directed the Union Public Service Commission and the Jharkhand Public Service Commission to...

SC reverses Tribunal Reforms Ordinance on age limit of lawyers as Tribunal members

New Delhi, Jul 15 (ILNS) The Supreme Court has reversed the provisions made to the Finance Act,...

SC issues notice on plea challenging Section 124A of Indian Penal Code

New Delhi, Jul 15 (ILNS) The Supreme Court today issued notice on a petition challenging the constitutional...

Rotary and Tata Trusts to collaborate in Cancer care, Covid care, Nutrition, Rural Uplift Livelihoods, to supplement efforts towards strengthening the nation

New Delhi, July 14 (ILNS) The Tata Trusts and Rotary today announced a five-year collaboration to scale...

Bar Council of Delhi distributed more than Rs 19 crore to lawyers during lockdown: BCD Chairman Ramesh Gupta

New Delhi, Jul 14 (ILNS) The Bar Council of Delhi is reaching out to the lawyers, who...

NGT flays Haryana over sewage overflow on National Highway-19

New Delhi, Jul 14 (ILNS) The National Green Tribunal has pulled up the state of Haryana over...

Must read

You might also likeRELATED
Recommended to you